Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion
Clinical trial NCT05657158 · COMPLETED
Trial details
- NCT number
- NCT05657158
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-23
- Primary completion
- 2022-01-04
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.